FJFarideh Jalali-Mashayekhi

Farideh Jalali-Mashayekhi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Farideh Jalali-Mashayekhi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Fatemeh Samimi

    Arak Univ Med Sci, Sch Med, Dept Biochem & Genet, Arak, Iran

    2 shared publications
  • Ali Ganji

    Department of Immunology, School of Medicine, Arak university of Medical Sciences, Arak, Iran

    1 shared publication
  • Ali Khosrowbeygi

    Department of Biochemistry and Genetics, School of Medicine, Arak University of Medical Sciences, Arak, Iran

    1 shared publication
  • Aniseh Hatami

    Student Research Committee, Arak University of Medical Sciences, Arak, Iran

    1 shared publication
  • Azam Moslemi

    Department of Biostatistics, School of Medicine, Arak University of Medical Sciences, Arak, Iran

    1 shared publication
  • Fateme Seidi

    Department of Obstetrics and Gynecology, School of Medicine, Arak University of Medical Sciences, Arak, Iran

    1 shared publication

Latest Publications

  • Open Access

    The Effect of Vitex Agnus - Castus Plant on Some Markers of Oxidative Stress, Lipid Profile and Insulin Resistance in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind Controlled Clinical Trial Study

    by Aniseh Hatami, Fateme Seidi, Ali Khosrowbeygi, Azam Moslemi, Farideh Jalali-Mashayekhi

    This randomized controlled trial investigated the efficacy of standardized Vitex agnus-castus extract in managing features of PCOS. The primary aim was to assess changes in oxidative stress markers; secondary outcomes included lipid profile, insulin resistance, and clinical signs such as hirsutism and menstrual frequency. Sixty women with PCOS were randomly assigned to a Vitex group (5.8 mg daily, standardized to 0.42-0.82 mg Aucubin) or placebo for 12 weeks. Dietary habits and physical activity and physical activity were maintained throughout the study. Serum total antioxidant capacity, glutathione peroxidase, reduced glutathione, and other biochemical and clinical parameters were assessed preand post-intervention. Between-group differences were analyzed using independent t-tests and ANCOVA. Compared to placebo, Vitex significantly increased total antioxidant capacity (effect size = 13.01), glutathione peroxidase (3.35), reduced glutathione (3.88), total thiol (3.34), and HDL (5.74) (all p<0.05). It decreased total oxidant status (-6.49), oxidative stress index (-9.30), malondialdehyde (-5.29), fasting blood sugar (-5.10), HOMA-IR (-0.31), LDL (-2.85), ALT (-3.51), and mFG score (-5.38). Menstrual frequency improved (3.51), and left ovarian volume reduced (-0.80). Vitex agnus-castus improved oxidative stress markers and insulin resistance and favorably modulated clinical manifestations of PCOS. These findings suggest a clinically meaningful benefit and support further investigation into Vitex as an adjunctive therapy.


  • Open Access

    Evaluation of Antioxidant Effects of Coenzyme Q10 against Hyperglycemia-Mediated Oxidative Stress by Focusing on Nrf2/Keap1/HO-1 Signaling Pathway in the Liver of Diabetic Rats

    by Fatemeh Samimi, Maryam Baazm, Zahra Nadi, Sanaz Dastghaib, Mehri Rezaei, Farideh Jalali-Mashayekhi

    Background: Hyperglycemia-induced oxidative stress can damage the liver and lead to diabetes complications. Coenzyme Q10 (CoQ10) reduces diabetes-related oxidative stress. However, its molecular mechanisms are still unclear. This study aimed to examine CoQ-10's antioxidant capabilities against hyperglycemia-induced oxidative stress in the livers of diabetic rats, specifically targeting the Nrf2/ Keap1/ARE signaling pathway. Methods: This study was conducted between 2020-2021 at Arak University of Medical Sciences. A total of 30 male adult Wistar rats (8 weeks old) weighing 220-250 g were randomly assigned to five groups (n=6 in each group): control healthy, sesame oil (CoQ-10 solvent), CoQ-10 (10 mg/Kg), diabetic, and diabetic+CoQ-10. Liver oxidative stress indicators, including malondialdehyde, catalase, glutathione peroxidase, and glutathione, were estimated using the spectrophotometry method. Nrf2, Keap1, HO-1, and NQO1 gene expressions were measured using real-time PCR tests in the liver tissue. All treatments were conducted for 6 weeks. Statistical analysis was performed using SPSS software. One-way ANOVA followed by LSD's or Tukey's post hoc tests were used to compare the results of different groups. P<0.05 was considered statistically significant. Results: The findings showed that induction of diabetes significantly increased Keap1 expression (2.1 +/- 0.9 folds, P=0.01), and significantly inhibited the mRNA expression of Nrf2 (0.38 +/- 0.2 folds, P=0.009), HO-1 (0.27 +/- 0.1 folds, P=0.02), and NQO1 (0.26 +/- 0.1 folds P=0.01), compared with the healthy group. In the diabetic group, the activity of glutathione peroxidase, catalase enzymes, and glutathione levels was decreased with an increase in malondialdehyde level. CoQ-10 supplementation significantly up-regulated the expressions of Nrf2 (0.85 +/- 0.3, P=0.04), HO-1 (0.94 +/- 0.2, P=0.04), NQO1 (0.88 +/- 0.5, P=0.03) genes, and inhibited Keap1 expression (1.1 +/- 0.6, P=0.02). Furthermore, as compared to control diabetic rats, CoQ-10 ameliorated oxidative stress by decreasing malondialdehyde levels and increasing catalase, glutathione peroxidase activities, and glutathione levels in the liver tissues of the treated rats in the treatment group. Conclusion: The findings of this study revealed that CoQ-10 could increase the antioxidant capacity of the liver tissue in diabetic rats by modulating the Nrf2/Keap1/HO-1/NQO1 signaling pathway.


  • Anti-parasitic effects of resveratrol on protoscolices and hydatid cyst layers

    by Ali Ganji, Farideh Jalali-Mashayekhi, Reza Hajihossein, Zahra Eslamirad, Parvin-Dokht Bayat, Mohammadhasan Sakhaie


  • Open Access

    Use of Nrf2 activators as a strategy to improve the side effects of Covid- 19

    by Fatemeh Samimi, Reza Azizi, Farideh Jalali Mashayekhi

    This paper is hypothesis letter and does not have abstract